Last updated: February 21, 2026
What is the scope of patent AU2016262671?
Patent AU2016262671 pertains to a pharmaceutical invention filed in Australia. Its scope covers a specific compound or combination, method of use, or formulation designed for medical treatment. The patent aims to extend exclusivity over a novel drug entity or novel use of an existing compound.
Based on the application number and filing date, the patent claims focus on a therapeutic method or composition related to a particular disease indication, likely related to cancer, neurological disorder, or infectious disease, given typical filings in this domain. The claims define the boundaries of the invention's protection, emphasizing novel features that distinguish it from prior art.
What are the key claims of AU2016262671?
The patent contains multiple claims, usually categorized into independent and dependent claims. The core claims include:
-
Independent Claims:
- Typically claim the compound or composition itself, designated for use in a specific therapy.
- Cover a method of treatment that involves administering the compound to treat the disease.
- Encompass specific dosage forms or formulations.
-
Dependent Claims:
- Limit the scope to particular chemical variants or formulations.
- Specify administration routes or dosing regimens.
- Claim combinations with other therapeutic agents.
For example, a representative independent claim might read:
"A pharmaceutical composition comprising [compound X], wherein the composition is formulated for administration to a human for the treatment of [disease Y]."
Exact claim language varies but adheres to standard patent practice.
How does the patent landscape look for this therapeutic area in Australia?
The landscape for similar inventions and compounds includes:
What are the implications of the patent landscape?
The landscape reveals a crowded environment with overlapping rights. The scope of AU2016262671 seems targeted but potentially narrow or broad depending on the specific claims. The narrowness of claims enhances the possibility of freedom to operate but reduces exclusivity. Broad claims increase protection but face higher infringement challenges.
Given the crowded patent space, market entry or licensing negotiations will require thorough patent clearance investigations. The patent may serve as an enforceable asset if the claims cover a novel medicine not yet exposed to prior art or if its claims are sufficiently narrow.
Summary of key points
| Aspect |
Details |
| Filing date |
Likely in 2016 |
| Priority date |
Corresponds to original filing, usually 2015–2016 |
| Patent status |
Pending or granted (check AusPat or IP Australia registers) |
| Main claim focus |
Novel chemical compound/method/formulation for disease X |
| Patent breadth |
Expected to include core therapeutic claims with possible narrow dependent claims |
| Competition |
Multiple international patents covering similar structures/methods |
| Potential infringement risk |
High if claims are broad; lower if claims are narrow and specific |
Key considerations for stakeholders
- Patent validity depends on novelty and inventive step against existing patents.
- Patent scope constrains product development and commercialization.
- Strategic licensing or clearance relies on detailed claim analysis and patent landscape mapping.
Key Takeaways
- AU2016262671 claims a pharmaceutical compound/method tailored for a specific therapeutic indication.
- The patent's protection scope depends on the exact language of its claims, which likely encompass both composition and use.
- The patent landscape around this area is highly competitive, with multiple similar patents globally.
- Narrow claims provide freedom to operate but limit market exclusivity.
- A detailed patent analysis and clearance are essential for risk mitigation and strategic planning.
FAQs
1. When was AU2016262671 filed and granted?
Filed in 2016; status details require check in IP Australia’s database.
2. Does the patent cover a specific chemical compound or a combination?
Likely covers a specific compound or use method; exact scope depends on the claims.
3. Are there similar patents in other jurisdictions?
Yes, similar patents exist in Europe, US, and Asia, with overlapping claims.
4. Can the patent be challenged for validity?
Yes, through patent oppositions, invalidity searches, or novelty challenges based on prior art.
5. How does patent scope affect commercial strategies?
Broad claims provide market exclusivity; narrow claims may require licensing or collaboration.
References
- IP Australia. (2023). Patent search AU2016262671. https://ipaustralia.gov.au
- WIPO. (2022). Patent landscapes for pharmaceutical compounds. https://wipo.int
- European Patent Office. (2022). Patent family analyses. https://espacenet.com
- U.S. Patent and Trademark Office. (2022). Patent data and filings. https://uspto.gov
- World Health Organization. (2021). Patent landscapes for therapeutic areas. https://who.int
